Synthesis and biological activity evaluation of podophyllotoxin-linked bile acid derivatives as potential anti-liver cancer agents

L. Siegel Rebecca, D. Miller Kimberly, E. Fuchs Hannah, et al., Cancer Statistics, 2021 [J]. CA: a cancer journal for clinicians, 2021, 71(1): 7-33. Yin, 2019, Natural products as important tyrosine kinase inhibitors[J], Eur. J. Med. Chem., 182, 111664, 10.1016/j.ejmech.2019.111664 Wang, 2018, Natural products targeting EGFR signaling pathways as potential anticancer drugs[J], Curr. Protein Pept. Sci., 19, 380, 10.2174/1389203718666170106104211 Cragg, 2009, Impact of natural products on developing new anti-cancer agents[J], Chem. Rev., 109, 3012, 10.1021/cr900019j Zhang, 2018, Podophyllotoxin derivatives as an excellent anticancer aspirant for future chemotherapy: a key current imminent needs[J], Bioorg. Med. Chem., 26, 340, 10.1016/j.bmc.2017.11.026 Cui, 2020, Lignans and their derivatives from plants as antivirals[J], Molecules, 25, 183, 10.3390/molecules25010183 Castro, 2003, Synthesis, cytotoxicity and antiviral activity of podophyllotoxin analogues modified in the E-ring[J], Eur. J. Med. Chem., 38, 899, 10.1016/j.ejmech.2003.05.001 Rappa, 1992, Potentiation by novobiocin of the cytotoxic activity of etoposide (VP-16) and teniposide (VM-26)[J], Int. J. Can., 51, 780, 10.1002/ijc.2910510519 Uno, 2001, In vitro induction of apoptosis for nasal angiocentric natural killer cell lymphoma-derived cell line, NK-YS, by etoposide and cyclosporine A[J], Br. J. Haematol., 113, 1009, 10.1046/j.1365-2141.2001.02844.x Carey, 2021, Bile acid permeation enhancement for inner ear cochlear drug pharmacological uptake: bio-nanotechnologies in chemotherapy-induced hearing loss[J], Therapeutic Delivery, 12, 807, 10.4155/tde-2021-0048 Park, 2017, Bile acid transporter mediated endocytosis of oral bile acid conjugated nanocomplex[J], Biomaterials, 147, 145, 10.1016/j.biomaterials.2017.09.022 Jin, 2014, Novel liver-specific nitric oxide (NO) releasing drugs with bile acid as both NO carrier and targeting ligand[J], Chin. Chem. Lett., 25, 787, 10.1016/j.cclet.2014.04.001 Mishra, 2020, Updates in bile acid-bioactive molecule conjugates and their applications[J], Steroids, 159, 108639, 10.1016/j.steroids.2020.108639 Zhang, 2016, Effective enhancement of hypoglycemic effect of insulin by liver-targeted nanoparticles containing cholic acid-modified chitosan derivative[J], Mol. Pharm., 13, 2433, 10.1021/acs.molpharmaceut.6b00188 Gong, 2021, Triformyl cholic acid and folic acid functionalized magnetic graphene oxide nanocomposites: Multiple-targeted dual-modal synergistic chemotherapy/photothermal therapy for liver cancer[J], J. Inorg. Biochem., 223, 111558, 10.1016/j.jinorgbio.2021.111558 Zhang, 2021, Enzyme-activated near-infrared fluorogenic probe with high-efficiency intrahepatic targeting ability for visualization of drug-induced liver injury[J], Chem. Sci., 12, 14855, 10.1039/D1SC04825B Zhang, 2018, Liver-targeted delivery of insulin-loaded nanoparticles via enterohepatic circulation of bile acids[J], Drug Delivery, 25, 1224, 10.1080/10717544.2018.1469685 Y. Gong, X. Zhang, Y. Zhang, et al., Bile acids, carriers of hepatoma-targeted drugs?[J]. Die Pharmazie-An Int. J. Pharm. Sci., 71(3) (2016) 139-145. Roda, 1996, Synthesis and physicochemical, biological, and pharmacological properties of new bile acids amidated with cyclic amino acids[J], J. Med. Chem., 39, 2270, 10.1021/jm9508503 Muthukumarasamyvel, 2016, Hierarchical self-assembly of bile-acid-derived dicationic amphiphiles and their toxicity assessment on microbial and mammalian systems[J], ACS Appl. Mater. Interfaces, 8, 25111, 10.1021/acsami.6b08018 El Kihel, 2008, New lithocholic and chenodeoxycholic piperazinylcarboxamides with antiproliferative and pro-apoptotic effects on human cancer cell lines[J], Bioorg. Med. Chem., 16, 8737, 10.1016/j.bmc.2008.07.046 Wu, 2018, Synthesis and biological evaluation of podophyllotoxin derivatives as selective antitumor agents[J], Eur. J. Med. Chem., 155, 183, 10.1016/j.ejmech.2018.05.052 Zhou, 2019, Synthesis and biological activity of glycyrrhetinic acid derivatives as antitumor agents[J], Eur. J. Med. Chem., 178, 623, 10.1016/j.ejmech.2019.06.029 Testa, 2017, Design, synthesis, in vitro characterization and preliminary imaging studies on fluorinated bile acid derivatives as PET tracers to study hepatic transporters[J], Bioorg. Med. Chem., 25, 963, 10.1016/j.bmc.2016.12.008 Liang, 2020, Design, synthesis and biological evaluation of naphthalenebenzimidizole platinum (II) complexes as potential antitumor agents[J], Eur. J. Med. Chem., 188, 112033, 10.1016/j.ejmech.2019.112033 Coghi, 2021, Synthesis, computational docking and biological evaluation of celastrol derivatives as dual inhibitors of SERCA and P-glycoprotein in cancer therapy[J], Eur. J. Med. Chem., 224, 10.1016/j.ejmech.2021.113676 Abbass, 2020, Design, efficient synthesis, docking studies, and anticancer evaluation of new quinoxalines as potential intercalative Topo II inhibitors and apoptosis inducers[J], Bioorg. Chem., 104, 10.1016/j.bioorg.2020.104255 Fan, 2020, F10, a new camptothecin derivative, was identified as a new orally–bioavailable, potent antitumor agent[J], Eur. J. Med. Chem., 202, 10.1016/j.ejmech.2020.112528 Chen, 2021, Water-soluble derivatives of evodiamine: Discovery of evodiamine-10-phosphate as an orally active antitumor lead compound[J], Eur. J. Med. Chem., 220, 10.1016/j.ejmech.2021.113544 Routholla, 2021, Design, synthesis and binding mode of interaction of novel small molecule o-hydroxy benzamides as HDAC3-selective inhibitors with promising antitumor effects in 4T1-Luc breast cancer xenograft model[J], Bioorg. Chem., 117, 10.1016/j.bioorg.2021.105446